IPACK Nerve Block for Total Knee Arthroplasty

Summary

Double-blind, randomized controlled clinical trial to test the efficacy of IPACK on postoperative opioid consumption, patient satisfaction, pain scores, mobility, and several other secondary outcomes in adults undergoing primary unilateral TKA. Enrolled patients will be randomized to either continuous ACB with IPACK or to continuous ACB with sham subcutaneous saline injection. Outcomes assessors and patients will be blinded to the intervention.

Timeline

Start

2016-11-17

Primary completion

2018-01-23

Completion

2018-01-23

Drugs

Indications